In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Entelos closes $20mm IPO

Executive Summary

US-based Entelos Inc., a biotech specializing in computer-generated, or in silico, laboratory technology, sold £11.4mm ($20mm) of stock in its initial public offering on the London Stock Exchange's AIM. It sold 13.8mm shares at 82.75 pence each.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies